Boothbay Fund Management, LLC Insmed Inc Call Options Transaction History

Boothbay Fund Management, LLC

  • $3.6 Billion
  • Q3 2024

Call Options

5 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$62.0 - $79.01 $7.16 Million - $9.13 Million
115,500 Added 77.41%
264,700 $19.3 Million
Q2 2024

Aug 14, 2024
BUY
$22.0 - $69.71 $220,000 - $697,099
10,000 Added 7.18%
149,200 $10 Million
Q1 2024

May 15, 2024
BUY
$25.72 - $29.94 $3.58 Million - $4.17 Million
139,200 New
139,200 $3.78 Million
Q1 2023

May 15, 2023
BUY
$16.26 - $21.73 $661,782 - $884,411
40,700 New
40,700 $693,000
Q3 2022

Nov 14, 2022
BUY
$20.88 - $28.21 $361,224 - $488,033
17,300 New
17,300 $373,000

Others Institutions Holding INSM

# of Institutions
467
Shares Held
182M
Call Options Held
2.27M
Put Options Held
3.33M
View Full List

About INSMED Inc

INSM Quotes by TradingView
  • Ticker INSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 135,476,992
  • Market Cap $10B
  • Description
  • Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...
More about INSM
Track This Portfolio

Track Boothbay Fund Management, LLC Portfolio

Follow Boothbay Fund Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Boothbay Fund Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email